Sofinnova Venture Partners VIII, L.P. → NuCana plc NCNA

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 11/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: +0.0%

Passive Schedule 13G filer baseline
Short interest building (+45.1% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

1 transaction

0 buys · 1 sales · 0 awards/exercises

Issuer Cluster

7 13D/G filings on this issuer

6 other filings besides this one

Filer Track Record

7 filings by this filer

6 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.02

145,031 shares short · +45.1% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-06-19	Levy Elliott M.	director	Disposition	23,811,896	—	—

Other 13D/G Filings on NuCana plc

Filed	Form	Filer	Stake	Shares
2025-02-25	SCHEDULE	Sofinnova Venture Partners VIII, L.P.	10.00%	51,030	view →
2025-02-14	SCHEDULE	SOFINNOVA CAPITAL VI FCPR	5.10%	4,987,975	view →
2021-06-15	SC	SOFINNOVA CAPITAL VI FCPR	—	—	view →
2021-02-02	SC	SOFINNOVA CAPITAL VI FCPR	—	—	view →
2020-10-28	SC	SOFINNOVA CAPITAL VI FCPR	—	—	view →
2019-02-14	SC	SOFINNOVA CAPITAL VI FCPR	—	—	view →

Other Filings by Sofinnova Venture Partners VIII, L.P.

Filed	Form	Issuer	Stake	Shares
2025-02-25	SCHEDULE	NuCana plc NCNA	10.00%	51,030	view →
2022-02-28	SC	ObsEva SA	—	—	view →
2021-03-04	SC	ObsEva SA	—	—	view →
2019-02-12	SC	Natera, Inc. NTRA	—	—	view →
2018-02-14	SC	Aclaris Therapeutics, Inc. ACRS	—	—	view →
2018-02-14	SC	SYNLOGIC, INC. SYBX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →